Abstract
Publications on the development and use of myocardial markers have exploded in the decade of the 1990s. According to subscriptions to proficiency testing surveys, enzymatic measurement of creatine kinase and lactate dehydrogenase isoenzymes have largely been replaced by CK-MB mass immunoassays. Laboratories reporting use of myoglobin and cardiac troponin have increased tremendously over the past few years. In this field of medicine where there have been dramatic changes, development of consensus guidelines can be helpful to provide assistance to clinicians and laboratorians as to how they can make the best use of new cardiac markers for clinical practice.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
